Company: BIVIW
Filing Date: 2025-05-15
Form Type: DRS
Source: 0001520138-25-000149
Chunk: 43

Company: BIOVIE INC.
Filing Date: 2025-05-15
Form: DRS
Chunk 43
---
 has acquired a controlling interest,
that is, crossing any of the three thresholds described above. We have not opted out of the control share statutes, and will be subject
to these statutes if we are an “issuing corporation” as defined in such statutes.

The effect of the Nevada control share statutes
is that the acquiring person, and those acting in association with the acquiring person, will obtain only such voting rights in the control
shares as are conferred by a resolution of the stockholders at an annual or special meeting. The Nevada control share law, if applicable,
could have the effect of discouraging takeovers of our Company.

Anti-Takeover Effects of Our Articles of
Incorporation and Bylaws

Our Articles of Incorporation and Bylaws contain
certain provisions that may have anti-takeover effects, making it more difficult for or preventing a third party from acquiring control
of us or changing our board of directors and management. According to our Articles of Incorporation and Bylaws, neither the holders of
our Common Stock nor the holders of any preferred stock we may issue in the future have cumulative voting rights in the election of our
directors. The combination of the present ownership by a few stockholders of a significant portion of our issued and outstanding Common
Stock and lack of cumulative voting makes it more difficult for other stockholders to replace our board of directors or for a third party
to obtain control of us by replacing our board of directors.

<div align='center'>29

Underwriting</div>

We have entered into an underwriting agreement
dated , 2025 with ThinkEquity LLC, as the representative
of the underwriters (the “Representative”), with respect to the securities sold in this offering. Subject to the terms and
conditions of the underwriting agreement, we have agreed to sell to the underwriters named below, and the underwriters have agreed, severally
and not jointly, to purchase from us the securities set forth opposite the underwriter’s name in the following table at the public
offering price less the underwriting discounts set forth in the cover page of this prospectus:

| Underwriter     |     | Number of 
 Units     |     | Number of        
 Pre-funded Units |
| ThinkEquity LLC |     |           |     |                  |
| Total           |     |           |     |                  |

The underwriters have committed to purchase all
of the securities offered by us other than those covered by the over-allotment option described below, if they